Adapalene
NDC Package 51672-2143-1
Package Information
Adapalene is a medication used to treat acne. Marketed by Taro Pharmaceuticals U.s.a., Inc., this product is identified by NDC 51672-2143 and is authorized under FDA application ANDA215940.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Taro Pharmaceuticals U.s.a., Inc.
- 51672-2143 - Adapalene
- 51672-2143-1 - 1 TUBE in 1 CARTON / 15 g in 1 TUBE
- 51672-2143 - Adapalene
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-2143). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-2143-1 identifies a specific commercial package of 1 tube in 1 carton / 15 g in 1 tube of Adapalene, labeled by Taro Pharmaceuticals U.s.a., Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Taro Pharmaceuticals U.s.a., Inc. on January 14, 2022. The current certification is valid through July 17, 2023.
What are the primary indications for this medication?
This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Adapalene belongs to a class of medications called retinoids. It works by affecting the growth of cells and decreasing swelling and inflammation.
How is this Taro Pharmaceuticals U.s.a., Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672214301. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.